MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2022.03.006

Медицинская библиотека · American heart journal · 2022

Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.

Erqou Sebhat, Papaila Alexa, Halladay Christopher, Ge Augustus, Liu Michael A, Jiang Lan, Lally Michelle, Menon Anupama, Shah Nishant R, Miech Edward, Virani Salim S, Zullo Andrew R, Shireman Theresa I, Longenecker Christopher T, Ross David, Sullivan Jennifer L, Wu Wen-Chih, Rudolph James L

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

People with HIV have increased atherosclerotic cardiovascular disease (ASCVD) risk, worse outcomes following incident ASCVD, and experience gaps in cardiovascular care, highlighting the need to improve delivery of preventive therapies in this population.

OBJECTIVE

Assess patient-level correlates and inter-facility variations in statin prescription among Veterans with HIV and known ASCVD.

METHODS

We studied Veterans with HIV and existing ASCVD, ie, coronary artery disease (CAD), ischemic cerebrovascular disease (ICVD), and peripheral arterial disease (PAD), who received care across 130 VA medical centers for the years 2018-2019. We assessed correlates of statin prescription using two-level hierarchical multivariable logistic regression. Median odds ratios (MORs) were used to quantify inter-facility variation in statin prescription.

RESULTS

Nine thousand six hundred eight Veterans with HIV and known ASCVD (mean age 64.3 ± 8.9 years, 97% male, 48% Black) were included. Only 68% of the participants were prescribed any-statin. Substantially higher statin prescription was observed for those with diabetes (adjusted odds ratio [OR] = 2.3, 95% confidence interval [CI], 2.0-2.6), history of coronary revascularization (OR = 4.0, CI, 3.2-5.0), and receiving antiretroviral therapy (OR = 3.0, CI, 2.7-3.4). Blacks (OR = 0.7, CI, 0.6-0.9), those with non-coronary ASCVD, ie, ICVD and/or PAD only, (OR 0.53, 95% CI: 0.48-0.57), and those with history of illicit substance use (OR=0.7, CI, 0.6-0.9) were less likely to be prescribed statins. There was significant variation in statin prescription across VA facilities (10th, 90th centile: 55%, 78%), with an estimated 20% higher likelihood of difference in statin prescription practice for two clinically similar individuals treated at two comparable facilities (adjusted MOR = 1.21, CI, 1.18-1.24), and a greater variation observed for Blacks or those with non-coronary ASCVD or history of illicit drug use.

CONCLUSION

In an analysis of large-scale VA data, we found suboptimal statin prescription and significant interfacility variation in statin prescription among Veterans with HIV and known ASCVD, particularly among Blacks and those with a history of non-coronary ASCVD.

Для цитирования: Erqou Sebhat, Papaila Alexa, Halladay Christopher, Ge Augustus, Liu Michael A, Jiang Lan, Lally Michelle, Menon Anupama, Shah Nishant R, Miech Edward, Virani Salim S, Zullo Andrew R, Shireman Theresa I, Longenecker Christopher T, Ross David, Sullivan Jennifer L, Wu Wen-Chih, Rudolph James L. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.. American heart journal. 2022. DOI: 10.1016/j.ahj.2022.03.006.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.